Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Anaptysbio (ANAB) Profit After Tax (2016 - 2025)

Anaptysbio filings provide 10 years of Profit After Tax readings, the most recent being $49.6 million for Q4 2025.

  • For the quarter ending Q4 2025, Profit After Tax rose 327.75% year-over-year to $49.6 million, compared with a TTM value of -$13.2 million through Dec 2025, up 90.89%, and an annual FY2025 reading of -$13.2 million, up 90.89% over the prior year.
  • Profit After Tax hit $49.6 million in Q4 2025 for Anaptysbio, up from $15.1 million in the prior quarter.
  • The five-year high for Profit After Tax was $49.6 million in Q4 2025, with the low at -$46.7 million in Q2 2024.
  • Median Profit After Tax over the past 5 years was -$33.2 million (2022), compared with a mean of -$25.4 million.
  • The sharpest move saw Profit After Tax crashed 7488.34% in 2022, then surged 327.75% in 2025.
  • Year by year, Profit After Tax stood at -$32.5 million in 2021, then rose by 18.82% to -$26.4 million in 2022, then plummeted by 59.81% to -$42.2 million in 2023, then soared by 48.39% to -$21.8 million in 2024, then skyrocketed by 327.75% to $49.6 million in 2025.
  • According to Business Quant data, Profit After Tax over the past three periods came in at $49.6 million, $15.1 million, and -$38.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.